Participants in both treatment groups showed improvement in visual acuity measures and a reduction in macular edema symptoms over six months.
Os participantes nos dous grupos de tratamento estudados mostraron melloras nas medidas de agudeza visual e na redución dos síntomas de edema macular en seis meses.